11 April 2023 in Antimicrobial Stewardship & Healthcare Epidemiology
Objective: To characterize personal exposures and measures of eye and respiratory tract irritation in controlled environmental chamber studies of 44 healthy adult volunteers simulating upper-bound use of peracetic acid (PAA)–based surface disinfectant for terminal cleaning of hospital patient rooms. Design: Experimental, within-subject, double-blinded cross-over design. Methods: Objective and subjective exposure effects were assessed for PAA and its components: acetic acid (AA) and hydrogen peroxide (HP). Deionized water was included as a control. Breathing-zone concentrations of PAA, AA, and HP were assessed for 8 female multiday volunteers (5 consecutive days) and 36 single-day volunteers (32 females and 4 males). Wetted cloths were used to wipe high-touch surfaces for 20 minutes per trial. Also, 15 objective measures of tissue injury or inflammation and 4 subjective odor or irritation scores were assessed. Results: Disinfectant trials showed 95th percentile breathing zone concentrations of 101 ppb PAA, 500 ppb AA, and 667 ppb HP. None of the volunteers observed over 75 test days exhibited significant increases in IgE or objective measures of eye and respiratory tract inflammation. Subjective ratings for disinfectant and AA-only trials showed similar increases for odor intensity and nose irritation, with lower ratings for eye and throat irritation. Females were 2.5-fold more likely than males to assign moderate + irritation ratings. Conclusions: Simulated upper-bound hospital use of PAA-based disinfectant led to no significant increases in objective markers of tissue injury, inflammation, or allergic sensitization, and no frank signs of eye or respiratory tract irritation.
1 August 2021 in Regulatory Toxicology and Pharmacology
11 March 2020 in Human and Ecological Risk Assessment: An International Journal
Airborne and surface Pb concentrations were measured inside a glovebox chamber with controlled inflow rate at 1.0 L/min of ultrapure air over a 4-hour period while an operator completed 1,680 solder connections using Sn63:Pb37 solder with rosin flux core. Chamber atmosphere showed released mean Pb mass of 0.0238 ± 0.011 μg and mean airborne concentration of 0.176 ± 0.085 μg/m3. Of the total solder mass used in two trials, on average 4.65% was recovered from the tip cleaning sponge and 0.14% dropped onto the work surface, with a surface loading rate of 0.30–0.45 μg/cm2. The estimated fingertip surface area in contact with solder wire was 14.7 cm2, with a measured average Pb mass of 14.9 μg, and a corresponding dermal loading rate of 1.01 μg/cm2. The waste solder dross surface area determined from digital micrographs in each trial were 1.65 and 2.43 cm2, with corresponding Pb density of 714 and 610 mg/cm2 and >90% of the detected dross mass comprising particles >100 μm in the widest dimension. Corresponding increases in blood Pb levels estimated using physiologically-based pharmacokinetic modeling were negligible compared with background. These findings demonstrate very low Pb emissions to air and surfaces during intensive manual microelectronic soldering activities.
3 June 2023 in Regulatory Toxicology and Pharmacology